Congressional Review Act

Cost-Benefit Analysis According to the Trump Administration

Scholar argues that the Trump Administration has discredited cost-benefit analysis.

OMB’s New Approach to Agency Guidance Documents

Research fellow argues that a recent OMB memo could improve regulatory lawmaking.

Which of Trump’s Regulatory Reforms Are Likely to Last?

In its novel effort to bring independent agency regulations under White House oversight, the Trump Administration may have found a lasting legacy.

Deregulatory Realities and Illusions

President Trump’s claims that deregulation has greatly helped the economy are exaggerated.

Getting Agencies Back Into the Game

Regulatory reform should reduce rulemaking burdens to promote effective agency action.

CRA Resolutions Against Agency Guidance Are Meaningless

GAO is wrong to think that Congress can use the CRA to overturn agency guidance.

Hyping the Cost of Regulation

Regulatory action should be based on accurate estimates of regulatory benefits and costs.

Guidance and the Congressional Review Act

Congress faces issues in attempting to apply regulation-removing law to agency guidance.

Repealing the CFPB’s Arbitration Rule

President Trump signs measure rescinding the financial consumer watchdog’s recent rule.

The CFPB’s Final Arbitration Rule Run Amok

New rule will raise costs, harming businesses, consumers, and the court system.

It Is Premature to Label a Regulatory Budget Unconstitutional

The President’s one-in, two-out executive order may be difficult to implement, but it is not unconstitutional.

A Wolf in Sheep’s Skin

The Early Participation in Regulations Act will further complicate the rulemaking process.